It is unknown whether SAXENDA causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), Nonclinical Toxicology (13.1)]
The jump from 1.0 mg to 2.4 mg roughly doubles the average weight loss, but it also increases side effect frequency
Enhanced Libido: By working on the brains arousal centers, it boosts sexual desire and performance
Stimulates procollagen production
Promisingly, because GLP-1 medications promote weight loss and, therefore, reduce fat tissue, they might help downregulate pro-inflammatory molecules